A detailed history of Di Nuzzo Private Wealth, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 12 shares of UTHR stock, worth $4,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 11 9.09%
Holding current value
$4,321
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$311.04 - $363.55 $311 - $363
1 Added 9.09%
12 $4,000
Q2 2024

Jul 30, 2024

BUY
$228.26 - $319.04 $228 - $319
1 Added 10.0%
11 $3,000
Q4 2023

Feb 05, 2024

BUY
$214.88 - $256.94 $2,148 - $2,569
10 New
10 $2.2 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Di Nuzzo Private Wealth, Inc. Portfolio

Follow Di Nuzzo Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Di Nuzzo Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Di Nuzzo Private Wealth, Inc. with notifications on news.